As the COVID virus continues to evolve, experts in respiratory diseases recommend that everyone ages 6 months and older ...

The Evanston college claims Moderna could not have developed the vaccine as quickly as it did in 2020 without its own ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

This week marked the start of the third-quarter earnings season, with Johnson & Johnson exceeding Wall Street’s expectations.

COVID has changed so much from the first few years of the pandemic, when people got those first vaccines in 2021,” said Dr. Doug Pogue, president of BJC Medical Group.

A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides difficile infection, more commonly known as C. difficile or C. diff. In animal ...

Northwestern University sued vaccine maker Moderna, Inc. on Wednesday, October 16, in the U.S. District Court for the ...

Moderna is facing allegations that it misused innovations from researchers at Northwestern University to develop its mRNA COVID-19 vaccines, which became widely available to the public in 2021 to ...

Factors associated with increased flare rates post-vaccination included active disease at the time, female sex, and -- most ...

In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new vaccines has become crucial.

Northwestern University has filed a lawsuit against Moderna, alleging the company used its patented lipid nanoparticle ...